107 related articles for article (PubMed ID: 7826142)
1. Increased mitogenic activity of scleroderma serum: inhibitory effect of human recombinant interferon-gamma.
Bryckaert M; Fontenay M; Lioté F; Bellucci S; Carriou R; Tobelem G
Ann Rheum Dis; 1994 Nov; 53(11):776-9. PubMed ID: 7826142
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels.
Rosenbloom J; Feldman G; Freundlich B; Jimenez SA
Arthritis Rheum; 1986 Jul; 29(7):851-6. PubMed ID: 3091039
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interferon-gamma inhibits the mitogenic effect of platelet-derived growth factor at a level distal to the growth factor receptor.
Hosang M
J Cell Physiol; 1988 Mar; 134(3):396-404. PubMed ID: 2832421
[TBL] [Abstract][Full Text] [Related]
4. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX
Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700
[TBL] [Abstract][Full Text] [Related]
5. Platelet acquired defect in PDGF and beta thromboglobulin content in hairy cell leukaemia: improvement after interferon therapy.
Dupuy E; Sigaux F; Bryckaert MC; Tobelem G; Castaigne S; Flandrin G; Degos L; Caen JP
Br J Haematol; 1987 Jan; 65(1):107-10. PubMed ID: 2949773
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic activities for skin fibroblasts in the sera from untreated scleroderma patients at the early stage.
Igarashi A; Takehara K; Soma Y; Kikuchi K; Ishibashi Y
Arch Dermatol Res; 1989; 281(6):383-6. PubMed ID: 2596866
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts.
Cho MM; Jimenez SA; Johnson BA; Harlow LA; Burrows JC; Koch AE
Pathobiology; 1994; 62(2):73-81. PubMed ID: 7945915
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of Triptolide on interferon-gamma-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves' ophthalmopathy.
Yan SX; Wang Y
Clin Exp Ophthalmol; 2006 Apr; 34(3):265-71. PubMed ID: 16671908
[TBL] [Abstract][Full Text] [Related]
9. [Growth factors in the pathogenesis of progressive systemic sclerosis].
Altomare GF; Polenghi MM; Pigatto PD; Florita S; Finzi AF
G Ital Dermatol Venereol; 1989 May; 124(5):187-92. PubMed ID: 2620917
[TBL] [Abstract][Full Text] [Related]
10. [Modulation of the organization of the extracellular matrix and the production of collagen by interferon gamma in three-dimensional cultures of normal and sclerodermic fibroblasts].
Serpier H; Gillery P; Polette M; Clavel C; Birembaut P; Kalis B; Cariou R; Maquart FX
Pathol Biol (Paris); 1992 Nov; 40(9):865-70. PubMed ID: 1296158
[TBL] [Abstract][Full Text] [Related]
11. Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts.
Unemori EN; Bauer EA; Amento EP
J Invest Dermatol; 1992 Sep; 99(3):337-42. PubMed ID: 1512471
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of platelet-derived growth factor activity in patients with progressive systemic sclerosis.
Pandolfi A; Florita M; Altomare G; Pigatto P; Donati MB; Poggi A
Proc Soc Exp Biol Med; 1989 May; 191(1):1-4. PubMed ID: 2717622
[TBL] [Abstract][Full Text] [Related]
13. Collagen synthesis by human fibroblasts. Regulation by transforming growth factor-beta in the presence of other inflammatory mediators.
Narayanan AS; Page RC; Swanson J
Biochem J; 1989 Jun; 260(2):463-9. PubMed ID: 2504143
[TBL] [Abstract][Full Text] [Related]
14. Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells?
Engström-Laurent A; Feltelius N; Hällgren R; Wasteson A
Ann Rheum Dis; 1985 Sep; 44(9):614-20. PubMed ID: 3876080
[TBL] [Abstract][Full Text] [Related]
15. Dipyridamole decreases platelet-derived growth factor levels in human serum.
Takehara K; Grotendorst GR; Silver R; LeRoy EC
Arteriosclerosis; 1987; 7(2):152-8. PubMed ID: 3579723
[TBL] [Abstract][Full Text] [Related]
16. Treatment of systemic sclerosis with gamma-interferon.
Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
[TBL] [Abstract][Full Text] [Related]
17. Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.
Fraticelli P; De Vita S; Franzolini N; Svegliati S; Scott CA; Tonnini C; Spadoni T; Gabrielli B; Pomponio G; Moroncini G; Gabrielli A
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S160-7. PubMed ID: 26339895
[TBL] [Abstract][Full Text] [Related]
18. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
19. Impaired growth response to endothelin-1 in scleroderma fibroblasts.
Kikuchi K; Kadono T; Sato S; Tamaki K; Takehara K
Biochem Biophys Res Commun; 1995 Feb; 207(2):829-38. PubMed ID: 7864878
[TBL] [Abstract][Full Text] [Related]
20. Immunoassay of platelet-derived growth factor in the plasma of patients with scleroderma.
Dunbar PR; Harrison A; Corkill MM; Neale TJ
Br J Rheumatol; 1993 Nov; 32(11):966-71. PubMed ID: 8220935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
